Background In an effort to determine whether specific genetic modifications of cells of the vascular system might improve the efficacy of existing clinical procedures such as endarterectomy, atherectomy, and percutaneous angioplasty, we investigated the utility of gene transfer to rapidly and efficiently repopulate injured arteries with genetically modified cells in an animal model.
The method involves the harvest of autologous venous-derived endothelial cells, the efficient genetic modification of the cells through the use of recombinant retroviruses, and the subsequent implantation of the genetically modified cells on the surface of balloon-denuded arterial segments. With a rabbit model, freshly isolated endothelial cells were transduced with a recombinant retrovirus encoding the bacterial enzyme 13-galactosidase. The autologous transduced cells were then implanted on the surface of balloondenuded ileofemoral arterial segments at different cell densities; after 1 to 14 days, the animals were killed, and the vessel segments were examined. Cells expressing the bacterial gene product, as determined by in situ staining for .3-galactosidase, were found to be present on the surface of 28 of the 32 arteries seeded with genetically modified cells. Vessels examined at 4 to 7 days after seeding displayed 40% to 90% coverage with transduced cells, even when seeded at subconfluent density, and an intact endothelial cell monolayer, as evidenced by scanning electron microscopy studies. Vessels examined at 14 days after seeding revealed more variable staining for 3-galactosidase yet, again, in most cases, an intact endothelial cell monolayer.
Conclusions These studies indicate the feasibility of generating segments of arterial vessels containing genetically modified cells in a rapid and efficient fashion. Further studies are now necessary to determine whether the local expression of specific polypeptides within a region of vessel for a finite period of time will be clinically useful. (Circulation. 1994; 23: 2161 -2169 Key Words * genetics * cardiovascular diseases R estenosis of blood vessels after surgical endarterectomy, percutaneous angioplasty, or other invasive procedures almost certainly occurs as a consequence of a very complex series of biological events involving both cellular constituents of the vessel wall and circulating blood elements (reviewed in References 1 and 2). One of the most striking physical manifestations of these events is the process of intimal hyperplasia,3, which involves the migration and subsequent proliferation of smooth muscle cells and matrix deposition in the intima.5 Accordingly, much attention has been placed on the characterization of normal and abnormal endothelial and smooth muscle cell function and the interactions between these two cell types.
Because the problem of restenosis involves discrete regions of the vasculature, a number of recent studies have considered the possibility of the delivery of products of potential therapeutic utility in a local fashion to favorably influence the interactions of endothelial cells (ECs), smooth muscle cells, and blood-derived elements at the site of injury.6,7 One potential means of delivering therapeutically useful products to specific regions of the vasculature that has only recently been considered involves the engineered expression of specific polypeptide products in cells of the vessel wall via gene-transfer techniques. [8] [9] [10] [11] [12] [13] In this regard, ECs are a particularly attractive target for such modifications because the cells can be readily isolated and cultured in vitro14"5 and efficiently transduced16"7 and, at least in preliminary studies, have been shown to be transplantable back onto denuded arterial segments. 9 Although previous studies have established the concept of gene transfer into ECs and demonstrated in a qualitative fashion that the reimplantation of genetically modified cells on blood-contacting surfaces is possible, a reliable method for generating segments of normal-appearing vasculature containing a high proportion of genetically modified ECs has not been reported. Toward this end, we studied the repopulation of denuded rabbit arteries with cultured, autologous genetically modified ECs. We report our initial experience in this model system, which demonstrates rapid reendothelialization of arteries by transduced cells seeded at confluent and subconfluent densities. (Fig 2a) . The results suggest that on average, most of the cells from each EC isolate carried a recombinant provirus (lanes 1 through 7) .
To directly determine the proportion of cells that expressed the bacterial enzyme, the transduced cells were exposed to X-gal, which when cleaved by galactosidase yield a blue precipitate that concentrates within each cell. The percentage of cells staining blue ranged from 40% to more than 95% for each of the isolates used in these experiments (representative staining of a transduced isolate is shown in Fig 2c) . Rabbit ECs exposed to viral particles lacking the LAC Z expression vector ("mock-infected, " Fig 2b) Explanted vessels were exposed to the X-gal reagent for 1 to 2 hours as described in "Methods" and then examined under a dissecting microscope, and the intimal surface was photographed sequentially. In initial experiments, transduced cells were resuspended for seeding in medium lacking autologous rabbit serum. Two animals were seeded in this fashion with transduced cells on one side and mock-infected cells on the contralateral artery. No cellular staining was observed on mock-infected arteries (Fig 3a) , whereas patchy blue staining was observed on the surface of arteries seeded with transduced cells (Fig 3b) Arteries examined between 4 and 7 days after seeding (n=11 vessels) were repopulated with blue cells covering 40% to 90% of their surfaces, whereas those seeded at higher densities ("confluent density") were more than 80% covered. A representative vessel seeded with 0.6x i0' cells/cm2 is shown in Fig 3d. Higher magnification of these surfaces suggested a punctate staining pattern on arteries with the transduced ECs (Fig 4g) , with alignment of cells in the direction of blood flow. Scanning electron microscopic analysis of four balloondenuded vessels incubated at the time of denudation with the "seeding" solution devoid of cells showed less than 15% coverage (data not shown).
In all cases involving vessels seeded with transduced cells, blue surface staining in a cellular pattern was revealed after short periods ( ing after short incubations of the vessels (1 to 2 hours) with X-gal (Fig 3a) . Prolonged incubation of the vessels often revealed a diffuse hazy staining pattern lacking cellular outlines (Fig 3e) . In the case of vessels seeded with transduced cells that were exposed to X-gal for long periods of time, both diffuse background staining and staining indicative of transduced cells were observed (Fig 3f) . Fig 4 summarizes (Fig 5A) . In contrast, each of the 7-(n=3) and 14-day (n=6) specimens examined was covered with a confluent, endothelial-appearing cell monolayer. Representative areas from 7-day and 14-day specimens that were more than 85% covered with blue cells on gross inspection are shown in Fig 5B and SD. The presence of intact intercellular junctions and the paucity of platelets and leukocytes suggest a quiescent surface. The five other 14-day arteries that were scanned (including two vessels without blue-staining cells and two vessels exhibiting patchy blue staining) exhibited a confluent endothelial monolayer. However, surfaces with partial coverage with 13-galactosidase-expressing cells exhibited a less quiescent appearance, with leukocytes and platelets adherent to the underlying endothelium and areas suggestive of ongoing EC turnover (eg, Fig SC) . Interestingly, even regions of vessels shown not to contain blue cells at day 7 or 14 appeared to be covered with ECs (see below).
Two distinct populations of cells possessing different electron densities were identified in areas of vessels densely covered with blue cells (Fig 5, all panels) . Energy-dispersive spectroscopy35 revealed the presence of strong bromine and chlorine signals in the more electron-dense cells (those appearing white on scanning electron microscopy) (data not shown). Because bromine and chlorine are both present in the X-gal reaction product, this suggests that the more electron-dense population seen by scanning electron microscopy corresponds to the population of 3-galactosidase-expressing genetically modified ECs.
Histological sections of transduced arteries revealed intense blue staining on the surfaces of explanted arteries (Fig 6) . Not surprisingly, with this method of denudation,36,37 significant medial injury was noted at 24 hours, with evidence of smooth muscle cell death and attenuation of the media (data not shown). At 14 days, intimal thickening was present beneath the layer of blue-staining cells on the luminal surface (Fig 6a) . A similar section from the same paraffin block stained with X-gal only demonstrates more clearly the presence of a monolayer of 1-galactosidase-expressing cells at the surface (Fig 6b) . In addition, less-intense blue regions visible in the deeper layers suggest either nonspecific background staining or expression of endogenous 3-galactosidase, perhaps by macrophages. Although no evidence of a significant cellular inflammatory response within the vessel wall could be seen at any of the time points examined, occasional areas with a sparse mononuclear infiltrate were infrequently observed at both 14 days and 1 week (data not shown (Fig 3e and Fig 6b) Although experiments are in progress to better understand the properties of vessels resurfaced in different ways and to increase the longevity of transduced gene expression, it is important to emphasize that in the absence of firm knowledge regarding the time course of biological events responsible for intimal thickening and, ultimately, restenosis, it is unclear whether the current seeding protocol needs to be improved for it to be clinically useful. Several studies, for example, suggest that the key events that trigger myointimal proliferation may occur within the first few days after vessel injury, 37 and therefore, that period may represent the only time necessary for intervention. If true, the transient nature of local delivery and the potential for achieving high local concentrations of therapeutic proteins afforded by our protocol, coupled with the likely eventual repopulation of the vessel segment with endogenously derived ECs, may be distinct advantages of the current system, particularly from the standpoint of safety and regulatory issues.
